ArticleScientific reports2022

Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease.

İlknur Ozturk Unsal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.